06 April 2020 – Lyell Immunopharma Gains $493m Investment from GlaxoSmithKline

CVC Unplugged - A podcast by Mawsonia - Mondays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

The Big Ones It is the sort of line to awaken the curiosity in an annual report: “Cash payments to acquire equity investments amounted to £258m…